Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$268.87 - $324.56 $4.3 Million - $5.2 Million
16,009 New
16,009 $4.55 Million
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $309,979 - $349,600
1,381 New
1,381 $311,000
Q3 2020

Nov 18, 2020

SELL
$234.65 - $260.95 $9.54 Million - $10.6 Million
-40,662 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$197.81 - $242.74 $6.15 Million - $7.55 Million
-31,107 Reduced 43.34%
40,662 $9.59 Million
Q1 2020

May 14, 2020

BUY
$182.24 - $241.7 $5.32 Million - $7.06 Million
29,203 Added 68.61%
71,769 $14.6 Million
Q4 2019

Feb 14, 2020

SELL
$189.21 - $243.2 $2.6 Million - $3.34 Million
-13,721 Reduced 24.38%
42,566 $10.3 Million
Q3 2019

Nov 14, 2019

SELL
$174.11 - $208.62 $17 Million - $20.3 Million
-97,500 Reduced 63.4%
56,287 $10.9 Million
Q2 2019

Aug 14, 2019

SELL
$166.7 - $195.41 $8.9 Million - $10.4 Million
-53,375 Reduced 25.76%
153,787 $28.3 Million
Q1 2019

May 14, 2019

SELL
$180.87 - $203.88 $15.4 Million - $17.4 Million
-85,297 Reduced 29.17%
207,162 $39.4 Million
Q4 2018

Feb 14, 2019

SELL
$178.4 - $208.25 $9.11 Million - $10.6 Million
-51,073 Reduced 14.87%
292,459 $56.9 Million
Q3 2018

Nov 14, 2018

BUY
$185.29 - $208.89 $2.56 Million - $2.88 Million
13,802 Added 4.19%
343,532 $71.2 Million
Q2 2018

Aug 13, 2018

BUY
$166.05 - $186.51 $10.2 Million - $11.5 Million
61,456 Added 22.91%
329,730 $60.9 Million
Q1 2018

May 15, 2018

BUY
$169.43 - $198.0 $11 Million - $12.9 Million
64,986 Added 31.97%
268,274 $45.7 Million
Q4 2017

Feb 09, 2018

BUY
$168.79 - $188.59 $6.49 Million - $7.26 Million
38,472 Added 23.34%
203,288 $35.4 Million
Q3 2017

Nov 14, 2017

BUY
$167.29 - $191.0 $9.07 Million - $10.4 Million
54,217 Added 49.02%
164,816 $30.7 Million
Q2 2017

Aug 15, 2017

BUY
N/A
44,000 Added 66.07%
110,599 $19 Million
Q1 2017

Aug 15, 2017

BUY
N/A
66,599
66,599 $10.9 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Chiron Investment Management, LLC Portfolio

Follow Chiron Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chiron Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chiron Investment Management, LLC with notifications on news.